Literature DB >> 28385346

Timing of surgical antimicrobial prophylaxis: a phase 3 randomised controlled trial.

Walter P Weber1, Edin Mujagic2, Marcel Zwahlen3, Marcel Bundi4, Henry Hoffmann2, Savas D Soysal2, Marko Kraljević2, Tarik Delko2, Marco von Strauss5, Lukas Iselin2, Richard X Sousa Da Silva4, Jasmin Zeindler2, Rachel Rosenthal6, Heidi Misteli2, Christoph Kindler7, Peter Müller7, Ramon Saccilotto8, Andrea Kopp Lugli9, Mark Kaufmann9, Lorenz Gürke2, Urs von Holzen10, Daniel Oertli2, Evelin Bucheli-Laffer11, Julia Landin2, Andreas F Widmer12, Christoph A Fux11, Walter R Marti4.   

Abstract

BACKGROUND: Based on observational studies, administration of surgical antimicrobial prophylaxis (SAP) for the prevention of surgical site infection (SSI) is recommended within 60 min before incision. However, the precise optimum timing is unknown. This trial compared early versus late administration of SAP before surgery.
METHODS: In this phase 3 randomised controlled superiority trial, we included general surgery adult inpatients (age ≥18 years) at two Swiss hospitals in Basel and Aarau. Patients were randomised centrally and stratified by hospital according to a pre-existing computer-generated list in a 1:1 ratio to receive SAP early in the anaesthesia room or late in the operating room. Patients and the outcome assessment team were blinded to group assignment. SAP consisted of single-shot, intravenous infusion of 1·5 g of cefuroxime, a commonly used cephalosporin with a short half-life, over 2-5 min (combined with 500 mg metronidazole in colorectal surgery). The primary endpoint was the occurrence of SSI within 30 days of surgery. The main analyses were by intention to treat. The trial is registered with ClinicalTrials.gov, number NCT01790529.
FINDINGS: Between Feb 21, 2013, and Aug 3, 2015, 5580 patients were randomly assigned to receive SAP early (2798 patients) or late (2782 patients). 5175 patients (2589 in the early group and 2586 in the late group) were analysed. Median administration time was 42 min before incision in the early group (IQR 30-55) and 16 min before incision in the late group (IQR 10-25). Inpatient follow-up rate was 100% (5175 of 5175 patients); outpatient 30-day follow-up rate was 88·8% (4596 of 5175), with an overall SSI rate of 5·1% (234 of 4596). Early administration of SAP did not significantly reduce the risk of SSI compared with late administration (odds ratio 0·93, 95% CI 0·72-1·21, p=0·601).
INTERPRETATION: Our findings do not support any narrowing of the 60-min window for the administration of a cephalosporin with a short half-life, thereby obviating the need for increasingly challenging SAP timing recommendations. FUNDING: Swiss National Science Foundation, Hospital of Aarau, University of Basel, Gottfried und Julia Bangerter-Rhyner Foundation, Hippocrate Foundation, and Nora van Meeuwen-Häfliger Foundation.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28385346     DOI: 10.1016/S1473-3099(17)30176-7

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  21 in total

1.  Antimicrobial Prophylaxis Redosing Reduces Surgical Site Infection Risk in Prolonged Duration Surgery Irrespective of Its Timing.

Authors:  Daniela Bertschi; Walter P Weber; Jasmin Zeindler; Daniel Stekhoven; Robert Mechera; Lilian Salm; Marco Kralijevic; Savas D Soysal; Marco von Strauss; Edin Mujagic; Walter R Marti
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

2.  Associations of Hospital Length of Stay with Surgical Site Infections.

Authors:  Edin Mujagic; Walter R Marti; Michael Coslovsky; Savas D Soysal; Robert Mechera; Marco von Strauss; Jasmin Zeindler; Franziska Saxer; Alexandra Mueller; Christoph A Fux; Christoph Kindler; Lorenz Gurke; Walter P Weber
Journal:  World J Surg       Date:  2018-12       Impact factor: 3.352

3.  Antimicrobial prophylaxis is critical for preventing surgical site infection.

Authors:  Gary Duclos; Laurent Zieleskiewicz; Marc Leone
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

4.  Surgical Antibiotic Prophylaxis and Risk for Postoperative Antibiotic-Resistant Infections.

Authors:  Margot E Cohen; Hojjat Salmasian; Jianhua Li; Jianfang Liu; Philip Zachariah; Jason D Wright; Daniel E Freedberg
Journal:  J Am Coll Surg       Date:  2017-10-10       Impact factor: 6.113

Review 5.  Guidelines for Perioperative Care in Elective Abdominal and Pelvic Surgery at Primary and Secondary Hospitals in Low-Middle-Income Countries (LMIC's): Enhanced Recovery After Surgery (ERAS) Society Recommendation.

Authors:  Ravi Oodit; Bruce M Biccard; Eugenio Panieri; Adrian O Alvarez; Marianna R S Sioson; Salome Maswime; Viju Thomas; Hyla-Louise Kluyts; Carol J Peden; Hans D de Boer; Mary Brindle; Nader K Francis; Gregg Nelson; Ulf O Gustafsson; Olle Ljungqvist
Journal:  World J Surg       Date:  2022-05-31       Impact factor: 3.282

6.  Prospective Analysis of Hand Infection Rates in Elective Soft Tissue Procedures of the Hand: The Role of Preoperative Antibiotics.

Authors:  Henrik C Bäcker; Christina E Freibott; Danielle Wilbur; Peter Tang; Richard Barth; Robert J Strauch; Melvin P Rosenwasser; Robert Neviaser
Journal:  Hand (N Y)       Date:  2019-04-15

7.  Surgical antimicrobial prophylaxis in intensive care unit (ICU) patients: a preliminary, observational, retrospective study.

Authors:  Gary Duclos; Bruno Pastene; Fanny Depeyre; Zoé Meresse; Nadim Cassir; Ignacio Martin-Loeches; Sharon Einav; Laurent Zieleskiewicz; Marc Leone
Journal:  Ann Transl Med       Date:  2018-10

8.  Optimal timing of surgical antimicrobial prophylaxis in laparoscopic surgery: a before-after study.

Authors:  Akane Takamatsu; Yasuaki Tagashira; Kaori Ishii; Yasuhiro Morita; Yasuharu Tokuda; Hitoshi Honda
Journal:  Antimicrob Resist Infect Control       Date:  2018-10-31       Impact factor: 4.887

9.  Effect of dexamethasone on complications or all cause mortality after major non-cardiac surgery: multicentre, double blind, randomised controlled trial.

Authors:  Karim Asehnoune; Charlene Le Moal; Gilles Lebuffe; Marguerite Le Penndu; Nolwen Chatel Josse; Matthieu Boisson; Thomas Lescot; Marion Faucher; Samir Jaber; Thomas Godet; Marc Leone; Cyrus Motamed; Jean Stephane David; Raphael Cinotti; Younes El Amine; Darius Liutkus; Matthias Garot; Antoine Marc; Anne Le Corre; Alexandre Thomasseau; Alexandra Jobert; Laurent Flet; Fanny Feuillet; Morgane Pere; Emmanuel Futier; Antoine Roquilly
Journal:  BMJ       Date:  2021-06-02

10.  Antibiotic prophylaxis in the ICU: to be or not to be administered for patients undergoing procedures?

Authors:  Ignacio Martin-Loeches; Marc Leone; Sharon Einav
Journal:  Intensive Care Med       Date:  2019-11-28       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.